11/13/2026 | Press release | Distributed by Public on 11/13/2026 15:56
ITEM 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
This Item 2, Management's Discussion and Analysis of Financial Condition and Results of Operations, and other parts of this Quarterly Report on Form 10-Q ("Quarterly Report") contain forward-looking statements, within the meaning of the safe harbor provisions under Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, that involve risks and uncertainties. Forward-looking statements reflect current expectations of future events based on certain assumptions and include any statement that does not directly relate to any historical or current fact. Forward-looking statements can also be identified by words such as "will," "believe," "could," "should," "would," "may," "anticipate," "intend," "plan," "estimate," "expect," "project" or the negative of these terms or other similar expressions. Forward-looking statements are not guarantees of future performance and our actual results may differ significantly from the results discussed in the forward-looking statements. Factors that might cause such differences include, but are not limited to, those discussed in Part II, Item 1A of this Quarterly Report. The following discussion should be read in conjunction with the audited consolidated financial statements and notes thereto included in Part II, Item 8 of our Annual Report on Form 10-K for the year ended December 31, 2025, as amended. We assume no obligation to revise or update any forward-looking statements for any reason, except as required by law.
Each of the terms the "Company," "INVE," "we," "us" and "our" as used herein refers collectively to INVE Technologies, Inc. (formerly Identiv, Inc.) and its wholly-owned subsidiaries, unless otherwise stated.
Overview
Beginning October 1, 2024 through September 15, 2026, we had one reportable segment: the IoT Business segment. The IoT Business developed, manufactured, and supplied specialty Internet of Things ("IoT") solutions tailored for the healthcare, logistics, smart packaging industries and other high-value end markets.
As disclosed in Note 1, Basis of Presentation and Note 3, Asset Sale, on September 15, 2026, we completed the sale of our IoT Business (the "Closing"). As a result, we no longer have an operating and reportable segment.
Following Closing, we changed our name to INVE Technologies, Inc., and we intend to operate as a publicly traded physical artificial intelligence ("AI") solutions business focused on acquiring and operating software-as-a-service ("SaaS") businesses in highly regulated industries that provide compliance, operations, traceability and regulatory software solutions that we believe may benefit from the integration with the physical AI platform of Trackonomy Systems, Inc. ("Trackonomy"), including the incorporation of bluetooth low energy ("BLE") and radio-frequency identification ("RFID") enabled physical data (such anticipated business, the "Physical AI Solutions Business").
Recent Developments
Closing of Asset Sale
On September 15, 2026, we completed the sale of our IoT Business through the sale of substantially all of our operating assets, including all outstanding shares of Identiv (Thailand) Co., Ltd, our wholly-owned subsidiary, and $25 million in cash, subject to adjustment, to Trackonomy pursuant to a Stock and Asset Purchase Agreement, dated as of June 24, 2026, by and between us and Trackonomy. As consideration for the Asset Sale, we received $50 million of shares of Series C Preferred Stock of Trackonomy, with a fair value of $20.07 per share.
In connection with the Closing, we and Trackonomy entered into a transition services agreement (the "Transition Services Agreement"). The Transition Services Agreement outlines the information technology and personnel support we will provide to Trackonomy for a period of 6 months to 12 months after the transaction closing date.
In addition, at the Closing, unvested restricted stock units ("RSUs") held by all employees, both those employees who became employed by Trackonomy and those remaining with the Physical AI Solutions Business became fully vested. RSUs held by our non-employee directors will remain outstanding and continue to vest according to their terms. During the three and nine months ended September 30, 2026, the Company recognized approximately $1.2 million of stock-based compensation expense attributed to the accelerated vesting.
In addition, employees who became employed by Trackonomy are entitled to receive a pro-rated payment in respect of their annual (or other short-term) cash bonus and/or commission opportunity which has a performance period that is ongoing as of the Closing. The amount of such payment shall be determined based upon actual performance achieved as of the date of the Closing in accordance with the terms of the applicable plan or arrangement and multiplied by a proration factor.
In addition, certain of our employees, including Edward Kirnbauer, our Chief Financial Officer, are eligible to receive a transaction bonus in connection with the Asset Sale, payable upon the earlier of (a) the conclusion of a retention period following the Closing and (b) the dissolution of the Company, subject to the employee's continuous service through such date (or as otherwise approved by the Company). The retention period ranges from six months to twelve months.
Factors Affecting Our Performance
As a result of the Closing, we currently have no commercial operating revenue. In addition, we transitioned our corporate strategy to operate as a physical AI solutions business focused on acquiring and operating compliance and specialized enterprise SaaS businesses in highly regulated industries. Our cash inflows will consist of payments for transition services to Trackonomy, if any, and interest income. We continue to incur public company expenses despite our substantially reduced operations and revenue, and our cash resources will be reduced by operating expenses, ongoing losses and the costs of operating as a public company. Although we are actively evaluating potential acquisition opportunities and currently intend to complete an acquisition as soon as possible, there can be no assurance that we will do so on the timeline currently expected or at all, or that any acquired business will generate sufficient revenue or cash flow to sustain our operations.
Because of this transaction and shift in strategy, our historical financial results are not indicative of our future operating performance. Our future financial condition, operating results, and long-term viability depend primarily on our ability to execute strategic acquisitions, integrate acquired businesses, and manage cash expenditures. Our future performance will be driven primarily by the following factors.
Identification, Execution, and Timing of Strategic SaaS Acquisitions
Our go-forward strategy depends on identifying and completing acquisitions of established enterprise SaaS businesses that provide compliance, operations, traceability, and regulatory software in highly regulated target markets. These target markets include healthcare operations, worker safety (EHS), pharmaceutical supply chains, food safety, medical device compliance, environmental and water quality management, and industrial operations. Because we currently have no operating revenue, our ability to generate revenue in future periods depends on the closing of these acquisitions or strategic relationships developed through this process.
We cannot guarantee that we will be able to identify suitable targets or negotiate acceptable terms. The acquisition process requires significant management time and focus, legal and advisory expenditures, and due diligence efforts. The timing of closing any acquisition is subject to negotiation dynamics, target company readiness, regulatory reviews, and prevailing market valuations. We intend to fund acquisitions through a combination of cash and structured equity, including time-vested equity, premium-priced options or warrants, and performance-based earnouts. If target companies or capital markets do not accept these transaction structures, our ability to complete acquisitions will be impaired, which would delay or prevent our ability to generate operating revenue.
Execution of Definitive Strategic Partnership with Trackonomy
Our business plan involves integrating Trackonomy's physical AI infrastructure, including smart BLE labels, RFID, sensors, telemetry, and structured data layers, into the software platforms of businesses we acquire. On November 9, 2026, the parties entered into a definitive strategic partnership agreement formalizing the commercial framework including commercial terms, technology commitments, and revenue-sharing provisions. We anticipate that this strategic partnership will provide an important technology foundation for our future growth strategy and support our efforts to create an integrated portfolio of business capable of benefiting from shared technology, data, and commercial capabilities, however, our commercial success will depend in part on Trackonomy's ability to manufacture, deliver, and support its hardware and software platforms on schedule and at competitive costs.
Integration, Customer Retention, and Expansion of Acquired SaaS Businesses
Following any acquisition, our operating results will depend on our ability to manage and scale the acquired operations. We expect acquired entities to continue generating recurring revenue while expanding product lines through the introduction of physical AI capabilities, premium service tiers, and hardware deployments. Key operational factors influencing our results may include customer retention and renewal rates within acquired customer bases, customer willingness to purchase premium subscription tiers and integrated physical monitoring features, engineering costs, timeframes, and technical challenges associated with integrating acquired software with Trackonomy data architecture, and our ability to consolidate acquired business operations and achieve general and administrative efficiencies.
Capital Resources and Corporate Expense Management
Our cash must support both acquisition activities and costs associated with operating as a public company. We currently expect to allocate approximately $30 million toward acquisitions and, beginning in 2027, approximately $12 million to $15 million to fund
corporate overhead and public company operating costs over an estimated three-year period.
Until we complete acquisitions that generate positive cash flow, we will experience operating losses and negative cash flows from operations. Our operating expenses include public company compliance, legal, accounting, corporate development, executive compensation, and other administration expenses. If corporate overhead exceeds expectations, or if target acquisitions take longer to execute than anticipated, our available cash could be significantly impacted. Furthermore, post-closing working capital adjustments from the sale of the IoT Business could alter our cash position. We expect acquisitions to be accretive to our cash position.
Leadership Transition and Recruitment
Execution of our business strategy transition requires senior leadership with significant experience in enterprise SaaS, technology mergers and acquisitions, and post-acquisition integration. In September 2026, our former Chief Executive Officer resigned, and an Interim Chief Executive Officer was appointed. Our operating performance will depend on our ability to attract and retain qualified executive leaders, including a permanent Chief Executive Officer, as well as corporate development professionals and technical integration personnel.
Impacts of Macroeconomic Conditions and Other Factors on Our Business
Although the sale of our IoT Business eliminated our direct exposure to manufacturing facility overhead, component supply lead times, and factory tariffs, our business remains subject to broader economic and regulatory risks. Economic downturns, high interest rates, and software budget reductions among enterprise customers could reduce demand for products sold by target companies and complicate acquisition valuations. Additionally, our strategy focuses on businesses operating under regulatory oversight. Shifts in federal or international compliance standards, enforcement priorities, or reporting requirements could alter customer demand for compliance software and automated tracking solutions.
For additional information regarding the risks we face, see "Risk Factors" in Part II, Item 1A of this Quarterly Report on Form 10-Q.
Results of Operations
Our results of operations for the three and nine months ended September 30, 2026 and 2025 are as follows (in thousands, except percentages).
|
Three Months Ended September 30, |
Nine Months Ended September 30, |
|||||||||||||||||||||||
|
2026 |
2025 |
% |
2026 |
2025 |
% |
|||||||||||||||||||
|
Net revenue |
$ |
3,088 |
$ |
5,009 |
(38 |
%) |
$ |
16,182 |
$ |
15,318 |
6 |
% |
||||||||||||
|
Gross profit |
564 |
534 |
6 |
% |
2,771 |
192 |
N.M. |
|||||||||||||||||
|
Gross profit margin |
18 |
% |
11 |
% |
17 |
% |
1 |
% |
||||||||||||||||
|
Operating expenses: |
||||||||||||||||||||||||
|
Research and development |
1,228 |
828 |
48 |
% |
3,179 |
2,505 |
27 |
% |
||||||||||||||||
|
Selling and marketing |
1,455 |
1,369 |
6 |
% |
4,094 |
4,322 |
(5 |
%) |
||||||||||||||||
|
General and administrative |
5,958 |
3,517 |
69 |
% |
13,209 |
9,720 |
36 |
% |
||||||||||||||||
|
Restructuring and severance |
164 |
402 |
(59 |
%) |
245 |
1,082 |
(77 |
%) |
||||||||||||||||
|
Total operating expenses |
8,805 |
6,116 |
44 |
% |
20,727 |
17,629 |
18 |
% |
||||||||||||||||
|
Loss from operations |
(8,241 |
) |
(5,582 |
) |
(17,956 |
) |
(17,437 |
) |
||||||||||||||||
|
Non-operating income (expense): |
||||||||||||||||||||||||
|
Interest income, net |
866 |
1,309 |
(34 |
%) |
2,908 |
3,841 |
(24 |
%) |
||||||||||||||||
|
Gain on Asset Sale |
6,127 |
- |
100 |
% |
6,127 |
- |
100 |
% |
||||||||||||||||
|
Net gain on dissolution of foreign subsidiary |
1,817 |
- |
100 |
% |
1,817 |
- |
100 |
% |
||||||||||||||||
|
Foreign currency gains (losses), net |
84 |
(25 |
) |
(436 |
%) |
(327 |
) |
(1,425 |
) |
(77 |
%) |
|||||||||||||
|
Income (loss) before income tax benefit (provision) |
653 |
(4,298 |
) |
(7,431 |
) |
(15,021 |
) |
|||||||||||||||||
|
Income tax benefit (provision) |
(65 |
) |
847 |
(108 |
%) |
(82 |
) |
739 |
(111 |
%) |
||||||||||||||
|
Net income (loss) |
$ |
588 |
$ |
(3,451 |
) |
$ |
(7,513 |
) |
$ |
(14,282 |
) |
|||||||||||||
|
N.M. - Not meaningful |
||||||||||||||||||||||||
Geographic net revenue based on each customer's ship-to location is as follows (in thousands):
|
Three Months Ended September 30, |
Nine Months Ended September 30, |
|||||||||||||||||||||||
|
2026 |
2025 |
% |
2026 |
2025 |
% |
|||||||||||||||||||
|
Americas |
$ |
1,771 |
$ |
2,571 |
(31 |
%) |
$ |
10,005 |
$ |
6,642 |
51 |
% |
||||||||||||
|
Europe and the Middle East |
817 |
1,236 |
(34 |
%) |
4,409 |
4,987 |
(12 |
%) |
||||||||||||||||
|
Asia-Pacific |
500 |
1,202 |
(58 |
%) |
1,768 |
3,689 |
(52 |
%) |
||||||||||||||||
|
Total |
$ |
3,088 |
$ |
5,009 |
$ |
16,182 |
$ |
15,318 |
||||||||||||||||
|
Percentage of net revenue: |
||||||||||||||||||||||||
|
Americas |
57 |
% |
51 |
% |
62 |
% |
43 |
% |
||||||||||||||||
|
Europe and the Middle East |
26 |
% |
25 |
% |
27 |
% |
33 |
% |
||||||||||||||||
|
Asia-Pacific |
17 |
% |
24 |
% |
11 |
% |
24 |
% |
||||||||||||||||
|
Total |
100 |
% |
100 |
% |
100 |
% |
100 |
% |
||||||||||||||||
Net Revenue
Net revenue for the three and nine months ended September 30, 2026 was $3.1 million and $16.2 million, respectively, compared with net revenue of $5.0 million and $15.3 million in the comparable periods of 2025. Net revenue in the Americas for the three and nine months ended September 30, 2026 decreased 31% and increased 51%, respectively, compared with the comparable periods of 2025. The decrease for the three months ended September 30, 2026 compared with the prior year period was due to lower unit sales of RFID transponder products, while the increase for the nine months ended September 30, 2026 compared to the comparable prior year period was primarily due to one of our customers ordering their full-year volume in the first quarter of 2026, totaling approximately $2.8 million. Net revenue in Europe, the Middle East, and the Asia-Pacific for the three and nine months ended September 30, 2026 was $1.3 million and $6.2 million, respectively, a decrease of 46% and 29%, respectively, compared with $2.4 million and $8.7 million in the comparable periods of 2025. The decreases were primarily due to lower unit sales of RFID transponder products, including transitioning sales from contract manufacturers in the Asia-Pacific region to shipping directly to one of our large customers in the Americas. Net revenue for the three and nine months ended September 30, 2026 reflects only activity through September 15, 2026, the closing date of the Asset Sale, and therefore is not comparable to the full prior-year periods.
Gross Profit and Gross Margin
Gross profit for the three and nine months ended September 30, 2026 was $564,000 and $2.8 million, respectively, compared with a gross profit of $534,000 and $192,000 in the comparable periods of 2025. Gross profit represents net revenue less direct cost of product sales, manufacturing overhead, other costs directly related to preparing the product for sale including freight, scrap, and inventory adjustments, where applicable.
Gross profit margin for the three and nine months ended September 30, 2026 increased to 18% and 17%, respectively, from gross profit margins of 11% and 1% in the comparable periods of 2025. The increases in gross profit margin were primarily attributable to cost savings and efficiencies achieved in procurement and production with the transition of production to our Thailand production facility, improved facility utilization, and the elimination of manufacturing production costs associated with our discontinued Singapore operation. In addition, the improvement in gross profit margin in the nine months ended September 30, 2026 was the result of charges to cost of revenue of approximately $639,000 during the nine months ended September 30, 2025, related to the write-down of obsolete inventory at our Singapore production facility.
Operating Expenses
Information about our operating expenses for the three and nine months ended September 30, 2026 and 2025 is set forth below (dollars in thousands).
Research and Development
|
Three Months Ended September 30, |
Nine Months Ended September 30, |
|||||||||||||||||||||||
|
2026 |
2025 |
% |
2026 |
2025 |
% |
|||||||||||||||||||
|
Research and development |
$ |
1,228 |
$ |
828 |
48 |
% |
$ |
3,179 |
$ |
2,505 |
27 |
% |
||||||||||||
|
as a % of net revenue |
40 |
% |
17 |
% |
20 |
% |
16 |
% |
||||||||||||||||
Research and development expenses consist primarily of employee compensation and fees for the development of RFID and BLE inlays, labels, and tags. The majority of our research and development activities focused on the customization of existing products and the development of new offerings for emerging market opportunities.
Research and development expenses for the three and nine months ended September 30, 2026 increased in dollars compared to the comparable prior periods in 2025 primarily due to an increase in stock-based compensation expense attributable to the accelerated vesting of RSUs in connection with the Asset Sale, as well as increased development costs in 2026.
Research and development expenses for the three and nine months ended September 30, 2026 only reflects activity through the Closing. As a result, the increase in research and development expenses described above was partially offset by the reduction in operating activity following the Closing, and therefore is not comparable to the full prior-year periods.
Selling and Marketing
|
Three Months Ended September 30, |
Nine Months Ended September 30, |
|||||||||||||||||||||||
|
2026 |
2025 |
% |
2026 |
2025 |
% |
|||||||||||||||||||
|
Selling and marketing |
$ |
1,455 |
$ |
1,369 |
6 |
% |
$ |
4,094 |
$ |
4,322 |
(5 |
%) |
||||||||||||
|
as a % of net revenue |
47 |
% |
27 |
% |
25 |
% |
28 |
% |
||||||||||||||||
Selling and marketing expenses consist primarily of employee compensation as well as customer lead generation activities, tradeshow participation, advertising and other marketing and selling costs.
Selling and marketing expenses increased for the three months ended September 30, 2026 primarily due to higher stock-based compensation expense attributable to the accelerated vesting of RSUs in connection with the Asset Sale and higher professional fees, partially offset by lower payroll-related costs. Selling and marketing expenses for the nine months ended September 30, 2026 decreased compared to the comparable period in 2025 primarily due to lower payroll-related costs, trade show and travel related costs, attributable to lower headcount year over year.
Selling and marketing expenses for three and nine months ended September 30, 2026 were also affected by the Asset Sale, which significantly reduced selling and marketing activity after the Closing, and are therefore not comparable to the full prior-year periods.
General and Administrative
|
Three Months Ended September 30, |
Nine Months Ended September 30, |
|||||||||||||||||||||||
|
2026 |
2025 |
% |
2026 |
2025 |
% |
|||||||||||||||||||
|
General and administrative |
$ |
5,958 |
$ |
3,517 |
69 |
% |
$ |
13,209 |
$ |
9,720 |
36 |
% |
||||||||||||
|
as a % of net revenue |
193 |
% |
70 |
% |
82 |
% |
63 |
% |
||||||||||||||||
General and administrative expenses consist primarily of compensation expenses for employees performing administrative functions, and professional fees incurred for legal, auditing and other consulting services.
General and administrative expenses for the three and nine months ended September 30, 2026 increased compared to the comparable periods in 2025 primarily due to higher strategic review-related costs of $3.1 million and $5.0 million, respectively, partially offset by lower professional fees and external contractor expenses.
General and administrative expenses for three and nine months ended September 30, 2026 were also affected by the Asset Sale, which reduced general and administrative expenses activity after the Closing, and are therefore not comparable to the full prior-year periods.
Restructuring and Severance
|
Three Months Ended September 30, |
Nine Months Ended September 30, |
|||||||||||||||||||||||
|
2026 |
2025 |
% |
2026 |
2025 |
% |
|||||||||||||||||||
|
Restructuring and severance |
$ |
164 |
$ |
402 |
(59 |
%) |
$ |
245 |
$ |
1,082 |
(77 |
%) |
||||||||||||
Restructuring and severance expenses for the three and nine months ended September 30, 2026 consisted of severance costs of $127,000 and $183,000, respectively, and restructuring costs of $37,000 and $62,000, respectively, associated with shutdown-related activities at the Company's Singapore manufacturing facility and Japan sales office.
For the three and nine months ended September 30, 2025, restructuring expenses consisted of severance costs of $79,000 and $413,000, respectively, and impairments of an operating lease right-of-use asset of $323,000 and $669,000, respectively, primarily associated with shutdown-related activities and vacated production space at the Company's Singapore manufacturing facility.
Non-operating Income (Expense)
Information about our non-operating income (expense) for the three and nine months ended September 30, 2026 and 2025 is set forth below (dollars in thousands).
|
Three Months Ended September 30, |
Nine Months Ended September 30, |
|||||||||||||||||||||||
|
2026 |
2025 |
% |
2026 |
2025 |
% |
|||||||||||||||||||
|
Interest income, net |
$ |
866 |
$ |
1,309 |
(34 |
%) |
$ |
2,908 |
$ |
3,841 |
(24 |
%) |
||||||||||||
|
Gain on Asset Sale |
$ |
6,127 |
$ |
- |
100 |
% |
$ |
6,127 |
$ |
- |
100 |
% |
||||||||||||
|
Net gain on dissolution of foreign subsidiary |
$ |
1,817 |
$ |
- |
100 |
% |
$ |
1,817 |
$ |
- |
100 |
% |
||||||||||||
|
Foreign currency gains (losses), net |
$ |
84 |
$ |
(25 |
) |
(436 |
%) |
$ |
(327 |
) |
$ |
(1,425 |
) |
(77 |
%) |
|||||||||
Interest income, net consists of interest income generated on our cash equivalents net of interest costs. The decrease in interest income, net for the three and nine months ended September 30, 2026 compared to the comparable periods of 2025 was primarily attributable to lower average monthly balances on our money market accounts and treasury bills.
During the three and nine months ended September 30, 2026, the Company recognized a gain of $6.1 million upon completion of the Asset Sale, representing the excess of the consideration received for the net assets sold. There was no corresponding gain recorded in the comparable period of 2025.
During the three and nine months ended September 30, 2026, the Company recognized a net gain on the dissolution of one of its foreign subsidiaries of $1.8 million related to the derecognition of its cumulative foreign currency translation adjustment in the third quarter of 2026. There was no corresponding gain recorded in the comparable period of 2025.
Changes in currency valuation in the periods mainly were the result of exchange rate movements between the U.S. Dollar, the Euro and the Thai Baht. Our foreign currency gains and losses primarily result from the valuation of current assets and liabilities denominated in a currency other than the functional currency of the respective entity in the local financial statements.
Income Tax Benefit (Provision)
|
Three Months Ended September 30, |
Nine Months Ended September 30, |
|||||||||||||||||||||||
|
2026 |
2025 |
% |
2026 |
2025 |
% |
|||||||||||||||||||
|
Income tax benefit (provision) |
$ |
(65 |
) |
$ |
847 |
(108 |
%) |
$ |
(82 |
) |
$ |
739 |
(111 |
%) |
||||||||||
|
Effective tax rate |
(10 |
%) |
(20 |
%) |
1 |
% |
(5 |
%) |
||||||||||||||||
As of September 30, 2026, our deferred tax assets are fully offset by a valuation allowance. ASC 740, Income Taxes, provides for the recognition of deferred tax assets if realization of such assets is more likely than not. Based upon the weight of available evidence, which includes historical operating performance, reported cumulative net losses since inception and difficulty in accurately forecasting our future results, we provided a full valuation allowance against all of our net U.S. and foreign deferred tax assets. We reassess the need for our valuation allowance on a quarterly basis. If it is later determined that a portion or all of the valuation allowance is not required, it generally will be a benefit to the income tax provision in the period such determination is made.
We recorded an income tax provision for the three and nine months ended September 30, 2026. The income tax benefit for the three and nine months ended September 30, 2025 was primarily attributable to a state income tax payable adjustment related to fiscal year 2024. The effective tax rates for the three and nine months ended September 30, 2026 and 2025 differ from the federal statutory rate of 21% primarily due to a change in valuation allowance, and the estimated tax impact attributed to the Asset Sale.
Liquidity and Capital Resources
As of September 30, 2026, our working capital, defined as current assets less current liabilities, was $81.4 million, a decrease of $51.9 million compared to $133.3 million as of December 31, 2025. As of September 30, 2026, our cash, cash equivalents, and restricted cash balance was $87.1 million.
Our Board of Directors has previously announced that it intends to return up to $40 million of capital to stockholders, which may be accomplished through dividends or other distributions and share repurchases. On November 7, 2024, we announced that our Board of Directors authorized a stock repurchase program, effective November 15, 2024 (the "Stock Repurchase Program"), under which we could repurchase up to $10.0 million of shares of our common stock pursuant to Exchange Act Rule 10b-18. On June 24, 2026, our Board of Directors authorized an increase in the amount available under the Stock Repurchase Program to $40.0 million, in addition to approximately $1.9 million previously repurchased under the Stock Repurchase Program. Under the Stock Repurchase Program, we may repurchase shares of common stock on a discretionary basis from time to time through open market repurchases, privately negotiated transactions, or other means. The timing and amount of shares repurchased depends on a number of factors, including stock price, trading volume, general market and business conditions, liquidity and capital needs, and other factors. The Stock Repurchase Program does not obligate us to repurchase any specific dollar amount or acquire any specific number of shares of common stock. The Stock Repurchase Program has no expiration date and may be suspended or discontinued at any time without notice. As of September 30, 2026, approximately $38.2 million remained available under the Stock Repurchase Program. During the three and nine months ended September 30, 2026, the Company repurchased 611,144 shares of common stock under the Stock Repurchase Program.
On October 21, 2026, the Company commenced a modified "Dutch auction" tender offer to purchase up to $20 million in value of its outstanding common stock, $0.001 par value per share, at a price per share of not greater than $3.40 nor less than $2.85. The tender offer will expire at 5:00 P.M., New York City time, on Thursday, November 19, 2026, unless the offer is terminated or extended.
As our previously unremitted earnings have been subjected to U.S. federal income tax, we expect any repatriation of these earnings to the U.S. would not incur significant additional taxes related to such amounts. However, our estimates are provisional and subject to further analysis. Generally, most of our foreign subsidiaries have accumulated deficits and cash and cash equivalents that are held outside the United States are typically not cash generated from earnings that would be subject to tax upon repatriation if transferred to the United States. We have access to the cash held outside the United States to fund domestic operations and obligations without any material income tax consequences. As of September 30, 2026, the amount of cash included at such subsidiaries was $6.4 million. We have not, nor do we anticipate the need to, repatriate funds to the United States to satisfy domestic liquidity needs arising in the ordinary course of business.
We have historically incurred operating losses and negative cash flows from operating activities, and we expect to continue to incur losses in the future. As of September 30, 2026, we had an accumulated deficit of $365.6 million. During the nine months ended September 30, 2026, we had a net loss of $7.5 million.
We believe our existing cash and cash equivalents will be sufficient to satisfy our working capital needs to fund operations for at least the next twelve months. We may also use cash to acquire or invest in complementary businesses, technologies, services or products that would change our cash requirements. We may also choose to finance future acquisitions or our business through public or private equity offerings, debt financings or other arrangements. However, there can be no assurance that additional capital will be available to us or that such capital will be available to us on acceptable terms. If we raise funds by issuing equity securities, dilution to stockholders could result. Debt or any equity securities issued also may provide for rights, preferences or privileges senior to those of holders of our common stock. The terms of debt securities issued or borrowings could impose significant restrictions on our operations. The incurrence of additional indebtedness or the issuance of certain debt or equity securities could result in increased fixed payment obligations and could also result in restrictive covenants, such as limitations on our ability to incur additional debt or issue additional equity, limitations on our ability to acquire or license intellectual property rights and other operating restrictions that could adversely affect our ability to conduct our business. In addition, the issuance of additional equity securities by us, or the possibility of such issuance, may cause the market price of our common stock to decline. If we are not able to secure additional funding when needed, we may have to curtail or reduce the scope of our business or forgo potential business opportunities.
The following summarizes our cash flows for the nine months ended September 30, 2026 and 2025 (in thousands):
|
Nine Months Ended September 30, |
||||||||
|
2026 |
2025 |
|||||||
|
Net cash used in operating activities |
$ |
(13,776 |
) |
$ |
(9,729 |
) |
||
|
Net cash used in investing activities |
(25,175 |
) |
(607 |
) |
||||
|
Net cash used in financing activities |
(2,708 |
) |
(398 |
) |
||||
|
Effect of exchange rates on cash, cash equivalents, and restricted cash |
(161 |
) |
1,354 |
|||||
|
Net decrease in cash, cash equivalents, and restricted cash |
(41,820 |
) |
(9,380 |
) |
||||
|
Cash, cash equivalents, and restricted cash at beginning of period |
128,909 |
135,946 |
||||||
|
Cash, cash equivalents, and restricted cash at end of period |
$ |
87,089 |
$ |
126,566 |
||||
Cash flows from operating activities
Cash used in operating activities for the nine months ended September 30, 2026 of $13.8 million was primarily due to a net loss of $7.5 million, a decrease in cash from net changes in operating assets and liabilities of $3.0 million and adjustments to net loss for certain non-cash items of $3.3 million, primarily consisting of the gain on the Asset Sale, net gain on dissolution of foreign subsidiary, depreciation, amortization, and stock-based compensation.
Cash used in operating activities for the nine months ended September 30, 2025 of $9.7 million was primarily due to a net loss of $14.3 million, a decrease in cash from net changes in operating assets and liabilities of $430,000 and adjustments to net loss for certain non-cash items of $5.0 million, consisting of depreciation, amortization, stock-based compensation, and impairment of operating lease right-of-use asset.
Cash flows from investing activities
Cash used in investing activities for the nine months ended September 30, 2026 was $25.2 million which related primarily to cash paid in connection with the Asset Sale and capital expenditures for our manufacturing facility in Thailand and our research and development facility in Germany.
Cash used in investing activities for the nine months ended September 30, 2025 was $607,000 which related primarily to capital expenditures for our manufacturing facility in Thailand, partially offset by proceeds received from an investment.
Cash flows from financing activities
Cash used in financing activities for the nine months ended September 30, 2026 was $2.7 million, which related to repurchases of common stock and taxes paid associated with net share settlements of RSUs and PSUs.
Cash used in financing activities for the nine months ended September 30, 2025 was $398,000, which related to taxes paid associated with net share settlements of RSUs and PSUs.
Contractual Obligations
Prior to the Closing, we leased facilities, certain equipment, and automobiles under non-cancelable operating lease agreements. Following the Closing, we currently sublease office space on a month-to-month basis. See Note 13, Leases, in the accompanying notes to our condensed consolidated financial statements.
Our other long-term liabilities include gross unrecognized tax benefits, and related interest and penalties. At this time, we are unable to make a reasonably reliable estimate of the timing of payments in individual years in connection with these tax liabilities.
Off-Balance Sheet Arrangements
We have not entered into off-balance sheet arrangements, or issued guarantees to third parties.
Climate Change
We believe that neither climate change, nor governmental regulations related to climate change, have had a material effect on our business, financial condition or results of operations.
Critical Accounting Estimates
Our condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America. The preparation of these condensed consolidated financial statements requires management to establish accounting policies that contain estimates and assumptions that affect the amounts reported in the condensed consolidated financial statements and accompanying notes. These policies relate to revenue recognition, inventory, income taxes, long-lived assets, and stock-based compensation. We have other important accounting policies and practices; however, once adopted, these other policies either generally do not require us to make significant estimates or assumptions or otherwise only require implementation of the adopted policy and not a judgment as to the policy itself. Management bases its estimates and judgments on historical experience and on various other factors that we believe to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Despite our intention to establish accurate estimates and assumptions, actual results may differ from these estimates under different assumptions or conditions.
During the three months ended September 30, 2026, management believes there have been no significant changes to the items that we disclosed within our critical accounting policies and estimates in "Management's Discussion and Analysis of Financial Condition and Results of Operations" in our Annual Report on Form 10-K for the year ended December 31, 2025, as amended.
Recent Accounting Pronouncements
See Note 2, Significant Accounting Policies and Recent Accounting Pronouncements, in the accompanying notes to our unaudited condensed consolidated financial statements in Item 1 of Part I of this Quarterly Report for a description of recent accounting pronouncements, which is incorporated herein by reference.